chrisvoncsefalvay/vaers-outcomes huggingface dataset:
From the evening of the day I have received the vaccination, my left arm started to feel dull continuous pressure pain, progressed stronger and stronger as the time goes.  No treatment given.  Following day, the pain was worse and stayed same.  The IM insertion site was also painful to touch or pressure.  Then afternoon of the same day, I started nausea, light headache, dizziness, and occasionally chills  as well as occasional dry cough accompanied by itchy throat or without itchy throat.  At this point, I took Advil 200mg 1 tab around 3pm.  The muscle pain on my left arm and headache is eased but other symptoms stayed same at this time, 4:30pm.
experiencing a strange smell all around his body. Smells like blood; This spontaneous case was reported by a consumer and describes the occurrence of PAROSMIA (experiencing a strange smell all around his body. Smells like blood) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAROSMIA (experiencing a strange smell all around his body. Smells like blood). At the time of the report, PAROSMIA (experiencing a strange smell all around his body. Smells like blood) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
ID administration of 1st attempt - Wheal and observed leakage. Successful 2nd administration intradermally.
Redness, swelling, mild tenderness/itching at the site (L deltoid/SQ tissue lateral arm), was noted within 6 hours of vaccination.
STROKE; ALWAYS RINGING IN THE EARS; This spontaneous report received from a patient concerned an 87 year old female. The patient's weight was 153 pounds, and height was 67 inches. The patient's past medical history included strokes but the last one was a long time ago. The patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. The reporter state that, the patient was taking two vaccine shots and was halfway between the two vaccines (2 weeks) second one would be on 29-MAR-2021.  On 09-Mar-2021, the patient experienced TIA symptoms (feeling fuzzy, batch of color lights in her left eye, very slurred speech, difficulty understanding and difficulty in communication) and stated she was having a stroke. Patient also informed that she already had this a lot of time before, and her doctor told her to lay down, take an aspirin. Treatment medications (dates unspecified) included: acetylsalicylic acid.  On 2021, the subject experienced always ringing in the ears. The reporter stated that, the patient had severe hearing impairment as patient continuously complained that her ears were "always ringing an patient was unable to answer all the questions as she stated that she had to go for some physical therapy exercise and could not continue the discussion. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable The patient had not recovered from stroke, and the outcome of always ringing in the ears was not reported. This report was serious (Other Medically Important Condition).   Additional information was received on 18-Mar-2021. The following information was updated and incorporated into the narrative: The patient's demographics details (age and age group),event (Always ringing in the ears), reporter address details and other reference number.; Sender's Comments: V1:  The following information updates addition of event (always ringing in the ears),  patient's demographics details (age and age group), reporter details and other reference number. This updated information does not alter prior causality assessment of reported event.  20210316871-Covid-19 vaccine ad26.cov2.s-Stroke. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: MEDICAL HISTORY
4/29/11 at 12:30 PM developed rash on chest & one wrist - by about 4PM rash entire body & swelling hands & ears. Saw urgent care - advised take PO BENADRYL. 4/30/11 AM was fine - after starting moving around s/s returned also had "little" breathing problem. Saw ER - given BENADRYL shot & steroid shot. Fine remainder of day & next day. 5/2/11 s/s returned - saw ER again - steroid shot & oral steroid & PEPCID. As of 05/03/11 at 5 PM no s/s.
I saw that the vial was diluent and ready to use since we had a vaccine person in the morning I assumed that the vial was left there for the next person to use. Turns out that was not the case and it was left there from the day before. So vaccine was expired already by the time it was given to patient.
3-4 hrs after vaccination began low grade fever, aches, and heavy coughing. 24 hrs later and it has all gotten worse. My wife and daughter have the same.
Significant hair loss. Hair started falling out in August. Comes out in clumps when I wash it.
Three weeks after his second shot (mid-June 2021) he experienced hair loss; in one spot at first.  A dermatologist saw him and diagnosed Alopecia Areata and treated him with Kenalog dermal injections, topical clobetasol solution, and topical minoxidil solution.  Between July and November, he saw Doctor monthly, and each month more spots appeared and were treated.  Between Christmas and New Years of that year he lost 95% of the hair on his head.  He is bald now and losing his eyebrows and eyelashes.
Local reactions sore leg for 24 hrs, fever 102 and continuous crying for 48 hrs follwoing DTP/OPV immunization
Within hours after injection, area began to swell & sensitive with movement of my arm next morning extremely stiff & swollen & a little sensitive to movement still. Next day extremely red & hot, started moving downward on my arm, stayed hot & moving down for 2 day - 3 days. Then, lessened in redness & heat, but still visible today, but seeming to get better. Started using ice pack & ZYRTEC 10 mg on 7/5. Then replaced ZYRTEC w/BENADRYL on 7/6 25 mg BID & 7/7, 7/8, 7/9, 7/10. The redness & swelling is improved but now patient is noticing darkness under her eye. I am unsure if this is at all related to the reaction. Left message w/mfg to inquire.
Red, hot to touch, swollen and tender right arm. Started on Keflex for cellulitis.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 69-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD TIV vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 23-Oct-2018, the patient was administered FLUAD (TIV) [route of administration: intramuscular, anatomical location: left deltoid, batch number: 250802, expiry date: 30-Jun-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805417 was crossed linked to original case 201804863 due to same reporter.
This spontaneous report was received from a healthcare professional who reported that in January 2014, 21 improperly stored doses of ROTATEQ, (oral, dose, batch and lot number not reported) were administered by a clinic to an unspecified number of patients (age and gender were not reported). No adverse effects were reported. This is one of several reports from the same source. Follow up information has been received on 17-MAR-2014. All telephone attempts to obtain follow-up information had been unsuccessful. Follow up information has been received on 22-SEP-2014. Demographic details for each patient were provided. This report referred to a 15-year old male patient, who was allergic to sulfamide and had no illness at time of vaccination. This report did not correspond to a patient vaccinated with ROTATEQ. Instead, the reporter informed that this patient was vaccinated with the third dose of GARDASIL (intramuscular injection, batch/lot # J008423, expiration date 21-JAN-2016, in the right arm, route not reported), on 21-FEB-2014 at 2:50 PM. It was reported that this dose was spoiled since the refrigerator was too cold (onset of event also reported as 27-FEB-2014 at 10:00 AM). The patient's parent did not call back. No adverse event was reported for the patient. The outcome was reported by the reporter as unknown. This is one of several reports from the same source. Additional information is not expected since all follow ups requested to complete the case were received.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 26-MAY-2021 the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) (strength was not reported; dose: 0.5 milliliter, lot # was T019423 and expiration date was 02-DEC-2021) and varicella virus vaccine live (oka/merck)(VARIVAX) (strength was not reported; dose: 0.5 milliliter, lot # was S021320 and expiration date was 09-JUL-2021) via intramuscular for prophylaxis (wrong product administered; incorrect route of product administration). No additional adverse event (AE) or product quality complaint (PQC) was reported.
they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     It was unknown patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was unknown patient had any relevant medical history or conditions, allergy, concomitant diseases and risk factor.     On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (they had a patient who potentially received (they were not sure) a Moderna COVID-19 Vaccine Bivalent instead of a monovalent vaccine for the primary series).    No concomitant medications was provided. No treatment medications was provided.
This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with the third dose of GARDASIL (dose and lot number not provided), 1 single shot intramuscularly. On an unknown date after the third shot of GARDASIL, the patient experienced fatigue. There was no mention of the 1st and 2nd shots. The outcome of fatigue was unknown. The causal relationship was not provided. Additional information has been requested.
Client received Flu shot and PNU shot both on 11/18/10. States he developed a 2" x 3" oval area on (L) arm about 5 inches below injection site. Area is tender & slightly pink & warm but exact area of injection is unaffected. Referred to PP for assessment & Rx. 11/22/10 FU tc to client - "Rxn worse" 11/19 but resolving on 11/20 & by 11/21 all s/s gone.
Lichen Planus....steroid creams and pills. Pills for 10 days with some improve in between doses. However, after the send dose the symptoms and bumps returned.
Patient said they developed an itchy red bump at the injection site area and on her forearm. It was about the size of a dime and has not gotten worse since appearing the day after her injection.
same tested positive for COVID; took the test because, that morning learned that was exposed to someone positive; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (same tested positive for COVID), EXPOSURE TO SARS-COV-2 (took the test because, that morning learned that was exposed to someone positive) and PAIN IN EXTREMITY (sore arm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concomitant products included DILTIAZEM, RIVAROXABAN (XARELTO), POTASSIUM, RIVASTIGMINE, METFORMIN, HYDROCHLOROTHIAZIDE, PAROXETINE, ATORVASTATIN, VITAMIN D3, DOXYCYCLINE HYCLATE, DEXAMETHASONE and FAMOTIDINE for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (same tested positive for COVID), EXPOSURE TO SARS-COV-2 (took the test because, that morning learned that was exposed to someone positive) and PAIN IN EXTREMITY (sore arm). At the time of the report, COVID-19 (same tested positive for COVID), EXPOSURE TO SARS-COV-2 (took the test because, that morning learned that was exposed to someone positive) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
On 6/1 Approximately 6 hrs post vaccination, I experienced swelling localized to the left eye and into the back of the head and cervical neck region, pressure and tingling which proceeded into the next day 6/2, later leading into the subsiding of swelling, and more of ?brain fog? or malaise on 6/3.   I had taken an antihistamine the night of the initial reaction, magnesium, quercetin, vitamin a,d,k, turmeric, colloidal silver, and zinc and oral arnica dissolvable  tablets. Symptoms had decently subsided, however the pressure on the left side of the head near the eye  and around onto the back of head toward the neck remained.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. The patient's concurrent conditions, drug reactions/allergies and medical history were not reported. On 23-JUN-2016, the patient was vaccinated with a dose of improperly stored ROTATEQ orally, lot number was L037921 and expiration date of 31-MAY-2017 (strength and dose were not reported). No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
During a vaccination clinic, a Pfizer vaccine was administered to an 11 year old patient. The patient's parent filled out the consent form and appointment with a incorrect DOB. When we went to process this claim we got an insurance rejection for incorrect DOB. After calling the parent she stated she intentionally filled it out incorrectly because she knew the minimum age was 12 and she wanted her son to get the vaccine. We cancelled the second dose appointment and advised her to wait until the child was 12 years old to schedule the second dose.
Myocarditis. Treatment and outcome have yet to be determined at the time of this note.
A legal complaint was received from an attorney concerning a male child who reportedly received his second dose of Hib-Titer vaccine on 3/19/98. The child received his first dose of Hib-Titer on 1/15/98. The legal complaint states that the child sustained neurological injuries as a result of exposure to thimerosal in the vaccines. The legal complaint states that as a result of those injuries, the child has been diagnosed with autism spectrum disorder. Mercury poisoning and autism were considered medically important (OMIC).
12 hours after second shot vomiting and diarrhea for 6 hours. Vertigo that I still have after a month of receiving shot
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (19 patients received an expired booster) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (19 patients received an expired booster). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (19 patients received an expired booster) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. This case was created for 1 of 19 patients who received expired vaccine. HCP stated that they had two lots from the Moderna vaccine in the freezer. They pulled one or two vials for a clinic, 30Nov2021, and administered 19 doses (all boosters). Later, they realized that the vials were expired. No treatment medication information was provided.
Pain at the site of injection (right deltoid), tender and red, warm to touch. Started around 8:30 pm on 8/7/2018.
On 9/25/17, employee came to EH. RUA red, rash noted, C/O itching. No crusting, no drainage, couple of bumps noted. Denies any fever or other symptoms. On 9/26/17 employee returned to EH. Rash resolving - no longer red, slightly pink, denies itching, using hydrocortisone cream PRN. No new areas noted.
Patient seen on 3/4/04 in employee health to follow up on a hand laceration. He complained of a bruise (discolored) arm, swelling and pain. 3/11/2004 patient again seen, pain still present, swelling decreased and discoloration decreased. 3/18/2004 not seen to feel nodular (swelling).
Rash to right arm which extended to shoulder, chest and neck. Benadryl 50mg IM administered. Within few minutes symptoms subsided.
This spontaneous report was received from a pharmacist refers to a patient of unknown age. On 03-APR-2015, the patient was vaccinated inadvertently with an expirted dose of ZOSTAVAX lot # J014567, expiry date 18-FEB-2015. No adverse events were reported. Additional information has been requested.
Td vax given 6SEP91 & 1245PM cold, clammy, dizzy; BP 88/50, p50, t97.2 by school nurse; Mom called & took pt to MD dx as hypotensive rxn;
No adverse effects; patient was administered improperly stored VAQTA; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, past medical history, concomitant medications, and drug reactions or allergies were not reported.  On 22-MAY-2019, the patient received an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) lot # R034339 with expiration date 23-NOV-2019 (strength, dose, route of administration were not reported), for prophylaxis. The dose of hepatitis a vaccine, inactivated (VAQTA) was exposed to a temperature excursion above 47 Fahrenheit degrees (°F) (9 Celsius degrees (°C)) (49.3 °F) during a timeframe of 44 minutes, which was not detected by a digital data logger. There were no previous temperature excursions. No adverse effects reported.    This is one of two cases from the same reporter.; Sender's Comments:  US-009507513-1905USA011144:
G1 P0 @ 20.5weeks with c/o blister, rash and pain on left arm at injection since yesterday S/P Flu Vaccine, family at side for support. Patient reports having Flu Vaccine in the past without any problems. PO BENADRYL 25mg given with directions to take TID PRN itching.
knot at injection site; feeling blah like about to get sick; head feels floaty; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling blah like about to get sick), FEELING ABNORMAL (head feels floaty) and VACCINATION SITE INDURATION (knot at injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced MALAISE (feeling blah like about to get sick) and FEELING ABNORMAL (head feels floaty). On an unknown date, the patient experienced VACCINATION SITE INDURATION (knot at injection site). At the time of the report, MALAISE (feeling blah like about to get sick), FEELING ABNORMAL (head feels floaty) and VACCINATION SITE INDURATION (knot at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Information has been received from a health professional concerning a 6 year old  white female with no known medical history or allergies who on 07/29/1999 was vaccinated SQ in her LA with a first dose of varicella vaccine live. On 02/16/2005 the pt developed only 10 lesions, Subsequently on 02/23/2005 the pt recovered. Addtional information is not expected.
Prior to immunization the patient was extremely nervous and stated he did not like blood and was also nervous about potential side effects. The pharmacist addressed his concerns and proceeded with the immunization. While the patient was in the waiting  area and decided to get up and walked over to report he was not feeling well and proceeded to faint.  911 was called and the patient refused treatment
pt was given vax 31JAN94 & on 1FEB93 the evening arm started to swell w/chills & temp 101; seen by MD 4FEB93 & arm remained redened & edematous;
Severe left shoulder pain/swelling. Left hand middle finger, joint pain, hand coldness, lips numbness then resolved with a dose of Prednisone orally. Symptoms persisted for 2 weeks after 7 days.
my glands under my jaw became tender after 24 hours. Over the weekend it progressed to feeling like an abcessed tooth, and I intended to see a dentist onMon.  by Mon the pain had decreased and by Tues. I could now put pressure on the back  left tooth with only slight pain.  The pain is still present,, but only slight.  Tylenol has been used successfully to alleviate the pain
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of 12 years old adolescent and unknown gender. On 03-SEP-2014 the patient was vaccinated with an improperly stored GARDASIL (lot J015378, expiration date 09-APR-2016) (dose, route, were not reported). No adverse effect was reported. The outcome of events reported is unknown. No product quality complaint was involved. This is one of several reports received from the same source. Additional information has been requested.